Walleye Capital
IART icon

Walleye Capital’s Integra LifeSciences IART Stock Holding History

Walleye Capital’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-218,595
Closed -$2.06M – 4924
2026
Q1 		$2.06M Buy
218,595
+146,203
+202% +$1.61M 0.01% 1442
2025
Q4 		$899K Buy
+72,392
New +$962K ﹤0.01% 2526
2024
Q4 		– Sell
-234,506
Closed -$4.26M – 5151
2024
Q3 		$4.26M Buy
234,506
+207,196
+759% +$4.8M 0.01% 1294
2024
Q2 		$796K Buy
27,310
+11,798
+76% +$350K ﹤0.01% 3069
2024
Q1 		$550K Buy
15,512
+10,186
+191% +$407K ﹤0.01% 3107
2023
Q4 		$232K Sell
5,326
-8,891
-63% -$350K ﹤0.01% 3578
2023
Q3 		$543K Buy
14,217
+5,031
+55% +$212K ﹤0.01% 2752
2023
Q2 		$378K Buy
+9,186
New +$442K ﹤0.01% 2644

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Walleye Capital's IART Position: Q2 2026 in Review

Walleye Capital sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 218,595 shares — an estimated $2.06M sold.

Walleye Capital first reported a position in IART in Q2 2023 and held it in 8 quarters. The position peaked at $4.26M in Q3 2024. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Walleye Capital reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 218,595 Integra LifeSciences shares in Q2 2026, an estimated $2.06M.
  • Walleye Capital first reported a position in Integra LifeSciences in Q2 2023 and held it in 8 quarters.
  • Walleye Capital's Integra LifeSciences position peaked at $4.26M in Q3 2024.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.